|1.||Constant, Stephanie L: 9 articles (12/2011 - 07/2005)|
|2.||Gallay, Philippe: 6 articles (02/2015 - 03/2008)|
|3.||Bukrinsky, Michael I: 6 articles (11/2011 - 07/2005)|
|4.||Hopkins, Sam: 5 articles (10/2015 - 08/2010)|
|5.||Bukrinsky, Michael: 5 articles (10/2015 - 03/2006)|
|6.||Lin, Kai: 5 articles (07/2013 - 09/2006)|
|7.||Fischer, Gunter: 4 articles (06/2015 - 01/2005)|
|8.||Wiedmann, Brigitte: 4 articles (10/2014 - 02/2010)|
|9.||Cunningham-Rundles, Charlotte: 4 articles (03/2013 - 08/2007)|
|10.||Geha, Raif S: 4 articles (07/2011 - 10/2007)|
10/01/2015 - "Cyclophilin polymorphism and virus infection."
02/19/2015 - "Bioengineering and semisynthesis of an optimized cyclophilin inhibitor for treatment of chronic viral infection."
01/01/2015 - "The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action."
08/01/2014 - "We found that cyclophilin inhibitors reduce phosphorylation of PKR and eIF2α during HCV infection to allow for translation of ISG products. "
08/01/2014 - "Cyclophilin inhibitors are being developed for treatment of hepatitis C virus (HCV) infection. "
02/01/2013 - "Cyclophilin inhibitors for hepatitis C therapy."
03/01/2011 - "The use of oral cyclophilin inhibitors as part of a combination regime for treatment of hepatitis C, especially to deter resistance, holds promise."
05/01/2009 - "The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients."
10/23/2014 - "Nonimmunosuppressive cyclophilin inhibitors have demonstrated efficacy for the treatment of hepatitis C infection (HCV). "
09/01/2007 - "Cyclophilin inhibitors in hepatitis C viral infection."
|4.||Psoriasis (Pustulosis Palmaris et Plantaris)
03/01/2006 - "Given that extracellular cyclophilins are potent chemotactic agents for various immune cells, further studies of the role of cyclophilin-CD147 interaction in inflammation followed. "
10/01/2015 - "Extracellular cyclophilins present an attractive target for therapeutic interventions that can be used to alleviate symptoms and consequences of acute and chronic inflammation. "
09/01/2007 - "Cyclophilins are secreted by a variety of cell types and are detected at high levels in tissues with ongoing inflammation. "
07/01/2005 - "These findings are the first to demonstrate the significant contribution of cyclophilins to inflammatory responses and provide a potentially novel approach for reducing inflammation-mediated diseases."
01/01/2013 - "Recent studies indicate a role of extracellular cyclophilins as contributors to endothelial inflammation and pathogenesis of atherosclerosis. "
|6.||Actins (F Actin)
|7.||B-Cell Maturation Antigen
|8.||Peptidylprolyl Isomerase (Prolyl Isomerase)
|9.||bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amine
|3.||Drug Therapy (Chemotherapy)